Article
- The EMBO Journal (2003) 22, 1381 - 1388
- doi:10.1093/emboj/cdg137
Subject Categories:
In vivo transposition mediated by V(D)J recombinase in human T lymphocytes
Terri L. Messier1,2, J.Patrick O'Neill2,3, Sai–Mei Hou4, Janice A. Nicklas2,3 and Barry A. Finette1,2,3,5
- Department of Pediatrics, University of Vermont, Burlington, VT 05405, USA
- Vermont Cancer Center, University of Vermont, Burlington, VT 05405, USA
- Genetics Laboratory, University of Vermont, Burlington, VT 05405, USA
- Department of Bioscience, Karolinska Institute, Huddinge, Sweden 141 57
- Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA
Correspondence to:
Barry A. Finette, E-mail: Barry.Finette@uvm.edu
Received 24 September 2002; Accepted 27 January 2003; Revised 9 January 2003
Abstract
The rearrangement of immunoglobulin (Ig) and T-cell receptor (TCR) genes in lymphocytes by V(D)J recombinase is essential for immunological diversity in humans. These DNA rearrangements involve cleavage by the RAG1 and RAG2 (RAG1/2) recombinase enzymes at recombination signal sequences (RSS). This reaction generates two products, cleaved signal ends and coding ends. Coding ends are ligated by non-homologous end-joining proteins to form a functional Ig or TCR gene product, while the signal ends form a signal joint. In vitro studies have demonstrated that RAG1/2 are capable of mediating the transposition of cleaved signal ends into non-specific sites of a target DNA molecule. However, to date, in vivo transposition of signal ends has not been demonstrated. We present evidence of in vivo inter-chromosomal transposition in humans mediated by V(D)J recombinase. T-cell isolates were shown to contain TCR
signal ends from chromosome 14 inserted into the X-linked hypo xanthine–guanine phosphoribosyl transferase locus, resulting in gene inactivation. These findings implicate V(D)J recombinase-mediated transposition as a mutagenic mechanism capable of deleterious genetic rearrangements in humans.
Keywords:
- HPRT,
- human T-cell receptor,
- RAG1/2,
- transposition,
- V(D)J recombination



